Glenmark Pharma’s arm receives USFDA’s approval for Pimecrolimus Cream

30 Aug 2019 Evaluate

Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Pimecrolimus Cream, 1%, a generic version of Elidel Cream, 1%, of Bausch Health US, LLC.

According to IQVIA sales data for the 12 month period ending July 2019, the Elidel Cream, 1% market achieved annual sales of approximately $198.8 million.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

398.05 4.45 (1.13%)
May 27, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 903.95
Cipla 966.30
Dr. Reddy's Lab 4392.00
Aurobindo Pharma 529.60
Lupin 606.15
View more..